Member Info for Wilson63

Tks to Kilkenny ted for finding this one

https://www.england.nhs.uk/wp-content/uploads/2020/11/diagnostics-recovery-and-renewal-independent-review-of-diagnostic-services-for-nhs-england-2.pdf

https://twitter.com/NovacytGroup/status/1443861500331020300

I'm not about to Diss other companies in the space but I've just been doing the rounds and reading recent news and twitter from other companies (well done to the shareholders) but frankly it's totally beyond comprehension, it doesn't matter what our resident pessimist has to say.
It's like your football bulletin boards , sack the manager, teams boring, why choose him.

Anything positive win a game make a good signing absolute zip always a player in the dressing room who spreads discontent. Imagine sharing a room with that player on a European trip, oh my giddy aunt.

Byp for every ying there is a yang I suppose I open the curtains in the morning and the sun has risen. I'd presume 90% of the time we will both view the company from different sides of the binoculars.

You didn't disappoint me in being the first to raise that Byp two things out of our control and both govt. related
1. Free lft tests.

2.long validation time.

However they can't affect this "significant "

Nice post by Larry, 3 fabulous bits of new yesterday which got understandably got lost in the Agm discussions. With regards to Co-prep and harking on this is exciting.

The new CO-Prep™ instrument has received significant interest from customers in advance of the launch next month. PROmate™ and Co-Prep™ have currently been designed for testing of COVID-19, but both testing and instrument technologies can be used to target additional diseases in the future.

Poidster we all have moments of doubt, it's just about standing back and looking at what the company has as you have.
Wbafc always possible but as yet we haven't suffered this fate, I'm led to believe scientists at times prefer to be at the coal face of innovation.

#imjustadriver

Byp I was hoping for a less knowledgeable poster so I could pull the rabbit from the hat.

Think we will have at least one Rns tomorrow very confident.:))

Neilrich3 thank you, that's also my belief just thought perhaps could change the narrative which understandably has been a bit hostile.

Co-prep, I'd presume no ifu's until launch

The new CO-Prep™ instrument has received significant interest from customers in advance of the launch next month. PROmate™ and Co-Prep™ have currently been designed for testing of COVID-19, but both testing and instrument technologies can be used to target additional diseases in the future.

So does "PROmate and CO prep" mentioned in this way mean they get used together to speed up the process even more?

Thought it might be nice on a dreary day to pick over the positives from the Rns as there quite obviously are some.

Tks to gasman and Bladesharp

https://mobile.twitter.com/blad3sharp/status/1443521414657716226/photo/1

La la la la America

Been busy some nice posters turning up.

Monkeyfish you've nailed it all other companies are in the queue, and a lot of other companies will be struggling to source materials, anyway let's see how it pans out today, off out Gla.

Very good and CO-prep launched.

Both delays are out of companies control in current climate.

Drb but there will be a meeting within five weeks of him starting, if that's not incentive to hit the ground running I don't know what is.

Sir_digby/bluelight I wanted an open meeting but felt slightly better when ygen(don't hold) also had a closed meeting and their shareholders were nowhere near as mad(ygen sh's confirm)

Crl please read Exmex's post earlier poster says Agm within 8 weeks 20% for egm no numbers for Agm (not verified) but I'd say Exmex is accurate in post.

Sir_digby I've watched it again, alas you've nailed it, excellent post.

Thanks Exmex interesting indeed so to clarify no minimum for ordinary meeting but 20% for extraordinary?

Gizmo555 am I looking in the wrong place or missing it(I'm presuming your alluding to some involvement)

https://www.cdc.gov/coronavirus/2019-ncov/variants/cdc-role-surveillance.html